University of Pennsylvania ScholarlyCommons Master of Science in Organizational Dynamics Theses 5-4-2010 Organizational Dynamics Programs Problems Facing the Pharmaceutical Industry and Approaches to Ensure Long Term Viability Donald A. Baines University of Pennsylvania‚ djtz00@aol.com Submitted to the Program of Organizational Dynamics in the Graduate division of the School of Arts and Sciences in Partial Fulfillment of the Requirements for the Degree of Master of Science in the Organizational
Premium Pharmaceutical industry Generic drug
integrating a multi-domestic enterprise Boltanski‚ L.‚ Chiapello‚ E.‚ 1999. Le novel esprit du capitalisme. Gallimard‚ Paris. Bredin‚ K.‚ Söderlund‚ J.‚ 2006. HRM and project intensification in R&D-based companies: a study of Volvo Car Corporation and AstraZeneca Carbone‚ T.A.‚ Gholston‚ S.‚ 2004. Project manager skill development: a survey of programs and practitioners Castells‚ 1996. The Rise of the Network Society. Blackwell‚ Oxford. De Meyer‚ A.‚ Loch‚ C.H.‚ Pich‚ M.T.‚ 2002. Managing project uncertainty:
Premium Project management
HistoryAetna‚ Inc. is an American health insurance company‚ which is the direct descendant of Aetna (Fire) Insurance Company‚ of Hartford‚ Connecticut. In 1850 Aetna began operation of an Annuity Fund and the company would soon to be known as Aetna Life Insurance Company. In 1899 Aetna became one of the first publicly held insurance companies to enter the health insurance field. Since then Aetna has become committed to providing access to cost-effective health care of the highest possible standard
Premium Health insurance Health care Health economics
company to dedicate a good deal of resources in order to get the drug to the patient. This is especially true when the company is a small to medium size company such as Medimmune. Medimmune‚ a global biologics research and development arm of AstraZeneca‚ has a yearly research and development budget of over one billion dollars. While this may seem like a large budget‚ Medimmune must allocate their resources to 120 research projects and product candidates currently in their pipeline. Their budget
Premium Project management Risk management
PharmaPoint: Type 2 Diabetes Global Drug Forecast and Market Analysis to 2022 On 01st JAN.2014 The type 2 diabetes market is mature and crowded with inexpensive generics. Despite being marked by a late-stage pipeline filled with me-too drugs‚ this market will undergo substantial growth between 2012 and 2022‚ more than doubling over this period. The main drivers of growth will be the dramatic increase in disease prevalence and physicians efforts to delay disease progression and reduce the costly
Premium Diabetes mellitus Clinical trial Diabetes mellitus type 2
SWOT analysis of the Glaxosmithkline. Glaxosmithkline is‚ after Pfizer Inc‚ the largest pharmaceutical company in the world. It was formed in 2000 as the result of a merger between two large companies GlaxoWellcome and SmithKlineBeecham. The company operates primarily in 117 countries‚ their products are currently manufactured in 37 and are sold in over 140 countries. It is headquartered in Brentford‚ England and employs about 110‚000 people with sales of Ł22.7bn. Their strategies for the future
Premium
ulcer disease (PUD)‚ gastroesophageal reflux disease (GORD/GERD)‚ laryngopharyngeal reflux (LPR)‚ and Zollinger-Ellison syndrome. It was first marketed in the US in 1989 by AstraZeneca under the brand names Losec and Prilosec‚ and is now also available from generic manufacturers under various brand names. AstraZeneca markets omeprazole as Losec‚ Antra‚ Gastroloc‚ Mopral‚ Omepral‚ and Prilosec. Omeprazole is marketed as Zegerid by Santarus‚ Prilosec OTC by Procter & Gamble and Zegerid OTC by
Premium Pharmaceutical industry Sales Generic drug
3Com 3M A Aalfs Manufacturing Aavid Thermal Technologies ABC-NACO Accenture Access Electronics Accuride Corporation Accuride International Adaptec ADC Adobe Systems Advanced Energy Industries Aetna Affiliated Computer Services AFS Technologies A.G. Edwards Agere Systems Agilent Technologies AIG Alamo Rent A Car Albany International Corp. Albertson’s Alcoa Alcoa Fujikura Allen Systems Group Alliance Semiconductor Allstate Alpha Thought Global Altria Group Amazon
Premium Oracle Corporation Manufacturing Industry
Brochure More information from http://www.researchandmarkets.com/reports/869/ Sales Force Structures and Strategies 2001: A Case Study Analysis of Effective Sales Force Management Description: As sales forces expand to maintain share of voice in an increasingly competitive market and physicians limit the time spent with sales representatives‚ ROI on detailing is in decline. Therefore‚ maximizing field force productivity is vital to the future success of all pharmaceutical companies. Sales Force
Premium Marketing Sales process engineering Sales force management system
The issue of the effectiveness of vaccines has been a long standing debate. Whether vaccines have indeed saved humanity countless times or has been the medium through which companies such as AstraZeneca can instill disease and thus fear unto humans for profit is a controversial topic. The one contributor of society that one would find astonishing to find opposing vaccines is doctors. One such doctor that found‚ in his experience‚ vaccines to be ineffective and arguably harmful is Dr. Harold Moskowitz
Premium Immune system Vaccine Vaccination